stein (I960) state that a first recognized embolus is fatal in about one in six so affected, and that one-half of the survivors die within three years, half of these because of recurrent embolism. Surgical measures designed to improve valve function, and to remove potential sources of clot formation, have been advocated for the prevention of this hazard. Among the many reports are those of Madden (I949), Belcher and Somerville (I955) , Glover (I956) , Turner and Fraser (1956) , Ellis, Harken, and Black (I959), Baker and Hancock (i960) , and Learoyd et al. (I960) . Kellogg et al. (I96I) and Taber and Lam (I960) emphasized the possible hazards of emboli occurring at operation, but Ellis and Harken (I96I) in a further review of their patients reasserted their belief in the protective value of mitral valvotomy against further emboli. They also thought that where mitral stenosis was present, the occurrence of a systemic embolus was in itself an indication for operation.
Subjects
This paper is based on 839 cases of rheumatic mitral valve disease seen at the Liverpool Regional Cardiac Centre between I952 and i965. Where follow-up was possible, assessments were made at 6-monthly intervals by at least one of the authors. We have attempted to study the incidence of arterial embolism, together with possible factors in its causation; and where cardiac operation Received I6 January i969.
has been undertaken, we have tried to evaluate its usefulness in the prevention of systemic emboli.
Of the 839 patients, 28 had systemic emboli before coming under review, but each of these patients was known to have had mitral valve disease before the embolism, and in no case was mitral valve disease recognized because of the occurrence of an embolus. For the purpose of this review, those patients having had systemic embolism as a result of bacterial endocarditis were excluded.
As judged by the usual criteria, i.e. clinical, electrocardiographic, and radiological, 737 patients had predominant mitral stenosis, and I02 had mitral regurgitation. This was an arbitrary division, and occasionally it was difficult to decide which was the dominant lesion, but stenosis was always considered the most important lesion in those cases put forward for closed mitral valvotomy.
In all, 74 patients (8 8°'%) had more than trivial aortic valve disease, and 17 of these had closed mitral and aortic valvotomy; 8 patients were found to have organic tricuspid valve disease, the diagnosis being based mainly on catheter findings, and in 3 of the 8, closed mitral and tricuspid valvotomy was performed.
Results
The total incidence of embolism is shown in Table i for mitral stenosis and in Table 2 for mitral regurgitation, with reference to the cardiac rhythm, the age of the patient, and disability graded according to the classification of the New York Heart Association (I964).
In both groups, there is an increasing incidence of embolic episodes with increasing age and with atrial fibrillation, but not Table  again shows the clear relation between atrial fibrillation and systemic embolism. Valve calcification has a much more significant effect upon the production of embolism at operation, as will be shown later.
Operative embolism We have adopted the criterion of Ellis and Harken (I96I) that an operative embolus is one that occurs in the operating room or any time before the patient is discharged from hospital after operation. Atrial clot, valve calcification, the type of operation, and the severity of the patient's disability have been considered as factors influencing the incidence of operative embolism.
(a) Atrial clot As would be expected, the risk of operative embolism is much greater in the presence of atrial clot, occurring in I4 of the go patients where such clot was found (15-5%) ( Multiple emboli occurring before followup There were 79 patients who had more than one recognizable embolus, 24 of them having more than one recurrence, the most being in one patient who had in all 7 preoperative embolic incidents. Seven of the patients were in sinus rhythm throughout, and in this small group only one of the recurrences was within 6 months of the original embolism. Three patients had sinus rhythm when examined after the first embolus and atrial fibrillation with the subsequent incidents.
At the time of the first embolus 69 patients had atrial fibrillation, 59 having had atrial fibrillation for at least 6 months, one for less than a month, and in 9 the duration of the arrhythmia was not known. However, the tendency of emboli to recur over a short period was shown by 23 There is a higher incidence of embolism with increasing age, a point also brought out by Bannister (I960), and with valve calcification, but the latter is probably a manifestation of the length of time the disease process has been established. It is made clear by our figures that atrial fibrillation is the main factor in the production of systemic embolism, and since the incidence of atrial fibrillation increases with the length of time the valve pathology has been present, it follows that increasing age and atrial fibrillation make systemic embolism a common feature of mitral valve disease. Thus, mitral stenosis with sinus rhythm gives an embolic incidence of 8 per cent over-all, 4-4 per cent below the age of 35, while atrial fibrillation is accompanied by systemic embolism in 3I-5 per cent of cases over-all, the figures being much the same when confined to patients aged 36 and over. These figures again broadly agree with those of the authors quoted above, plus Daley et al. (I95 I) , Jordan, Scheifley, and Edwards, (I9si), and Turner and Fraser (1956) .
Atrial fibrillation is associated with systemic embolism because it predisposes to clot formation in the atrium; 83 of the go patients in this series with atrial clot had atrial fibrillation. Turner and Fraser (I956) showed similar results, since 46 of their 48 patients, with discoverable atrial clot at operation were also in atrial fibrillation, and Lowther and Turner (I962) Pre-operative embolism does not increase the probability that left atrial clot will be present at operation, and hence that the risk of operative embolism will be increased, our findings being similar to those of Wood (I954). Turner and Fraser (1956) and Askey and Bernstein (I960) disagreed with Wood's findings, and thought that patients having had a systematic embolism were exposed to increased risk at operation.
Removal of the atrial appendage will reduce the possible sites of thrombus formation, but the earlier cases in our series, where mitral valvotomy was performed without atrial appendagectomy, have shown no greater tendency to post-operative embolism, than the later cases, where appendagectomy was routine. It is possible, of course, that the atrial suture line itself, after appendagectomy, may be a source of further thrombus formation, as described by Stewart and Glenn (I959) . The value of atrial appendagectomy in the prevention of systemic emboli has been overestimated, and it should never be undertaken as an isolated procedure. Our small series of patients who had lone atrial appendagectomy had a higher incidence of embolism in follow-up than any other group of our patients, surgically or medically treated.
There is a danger of producing emboli at operation, either from left atrial clot, or from fragments of calcium when this is present. Figures quoted for operative From the evidence provided in this series of patients, we think it possible to offer certain guiding principles of treatment with regard to the embolic risks in mitral valve disease. i When atrial fibrillation is present, the risk of systemic embolism is high. If the valve is operable, surgery will lessen this risk considerably, and should be considered even if there are few other symptoms. If embolism has occurred, then an operation is clearly indicated, and we have not been able to show that pre-operative anticoagulation reduces the number of cases where atrial clot is found at operation. 2 When sinus rhythm is present, when there is a disability of grade 2 or less, and when the patient is aged less than 35, mitral valvotomy does not lessen the risk of embolism, and 'prophylactic' valvotomy cannot be recommended on these grounds in these patients. Above the age of 35, still with sinus rhythm, and even if embolism has already occurred, valvotomy does not significantly lower the incidence of further emboli, and here the embolic risk cannot be used alone as an argument for operative intervention. In these cases long-term anticoagulation is probably the treatment of choice. 3 Instrumental valvotomy produces operative emboli in IO per cent of patients with calcified valves, and while not an absolute contraindication to closed mitral valve surgery, the presence of calcification visible on the x-ray is certainly an indication not to proceed with operation if this is to be done mainly to prevent emboli in the future.
